STEAP1 and prostate carcinoma: To investigate the global impact of STEAP1 loss in prostate cancer, we performed transcriptome profiling of the isogenic 22Rv1 wildtype (wt), 22Rv1 STEAP1 ko, and 22Rv1 STEAP1 ko + rescue cell lines we had previously prepared (Fig. 2b).